EF Hutton Acquisition Co. I reiterated their buy rating on shares of HCW Biologics (NASDAQ:HCWB – Get Rating) in a research report released on Thursday, Benzinga reports. The brokerage currently has a $9.00 price objective on the stock. HCW Biologics Stock Up 5.3 % Shares of HCWB opened at $1.40 on Thursday. HCW Biologics has […]